Henry Schein Inc

Henry Schein’s CEO receives a 30,723‑unit RSU grant—showing board confidence, aligning incentives, and signaling steady growth amid insider sales and health‑care tech trends.

Henry Schein CFO and top execs sell shares after earnings; investors weigh insider selling as possible sign of strategic shift or personal liquidity, but fundamentals stay strong.

Henry Schein insider moves signal a strategic shift to tech‑driven growth: CEO holds, chairman sells, KKR equity swaps boost capital for expansion and innovation.

Henry Schein CEO’s modest insider sales after an earnings beat—why a 0.4 % sell‑off signals confidence, not panic, in a growing dental‑healthcare firm.